AI in Drug Discovery: High-throughput SPR Boosts Breakthroughs
Read More
Parallel Measurements of Hundreds of TCR/pMHC Affinities Using The Carterra Surface Plasmon Resonance Technology
Read More
Carterra Poster | SLAS 2025 | Ultra Platform
Read More
Carterra Ships Its First Ultra Biosensor Platform and Finishes 2024 with Double-digit Growth and Record Revenues
Read More
Webinar: Massively Parallel SPR-Based Fragment Screening on Ligand Arrays
Read More
Carterra Interview | ELRIG Drug Discovery 2024 | Ultra Platform
Read More
Carterra unveils its most sensitive biosensor platform; Carterra Ultra™ ushers in a new frontier in fragment and small molecule drug discovery
Read More
Full Antigen Kinetics of Fabs Directly from Crude Periplasmic Extracts on an Anti-CH1 Capture Surface
Read More
Standard BioTools Purchases the Carterra® LSAXT System to Accelerate Data Delivery and Provide Greater Validation to SomaScan® Customers
Read More
IPA Acquires the Carterra LSA® Instrument to Enhance Antibody Discovery and Bolster Its AI Developments
Read More
